Sepsis

Original Editors - Leana Louw

Top Contributors - Lucinda hampton, Leana Louw, Rachael Lowe, Kim Jackson, Admin, Aminat Abolade, Uchechukwu Chukwuemeka and Carina Therese Magtibay

Introduction

Sepsis Treatment

Sepsis is life-threatening organ dysfunction resulting from a dysregulated response to infection by the host. Basically it is when this immune system response becomes overactive and starts to cause damage to the body itself. It is associated with high morbidity and mortality rates, being a final common pathway to death from many infectious diseases worldwide.

• Sepsis needs urgent treatment as it can quickly worsen.
• Sepsis clinical criteria: Organ dysfunction, which is is defined as an increase of 2 points or more in the Sequential Organ Failure Assessment (SOFA) score.

View this 3 minute video titled "Sepsis and Septic Shock, Animation."

Epidemiology

The worldwide burden of sepsis is hard to establish.

• A 2017 report estimated sepsis accounted for almost 20% of all global deaths, there being 48.9 million cases and 11 million sepsis-related deaths worldwide. Twice that thought previously
• Almost half of all global sepsis cases occurred among children in 2017.
• Roughly 85.0% of sepsis cases and sepsis-related deaths worldwide occurred in low- and middle-income countries.

Etiology

The 2009 European Prevalence of Infection in Intensive Care (EPIC II study) determined that gram-negative bacterial infections far exceed other etiologies as the most common cause of sepsis syndromes with a frequency of 62%, followed by gram-positive infections at 47%.

• An increase in the prevalence of the latter may be attributable to the performance of more invasive procedures and increased incidence of nosocomial infections.
• Predominant micro-organisms isolated in patients include Staphylococcus aureus (20%), Pseudomonas (20%), and Escherichia coli (16%). Predominant sites of infection include respiratory (42%), bloodstream (21%), and genitourinary (10%).
• The influence of bacterial strain and site of infection on mortality was illustrated in a large meta-analysis. In this study, gram-negative infections were overall associated with higher mortality.

Sepsis syndromes caused by multidrug-resistant bacterial strains (methicillin-resistant Staphylococcus, vancomycin-resistant enterococci ) are on the rise with a current incidence of up to 25%; viruses and parasites cause far fewer cases and are identified in 2% to 4% of cases

At risk populations

• Babies younger than 1 year
• People over 75
• Frail people
• Diabetics
• Immunocomprimised
• Perinatal women
• People who have recently had surgery
• People who have recently had a serious illness.

80% of sepsis cases are the result of the following infections:

• Chest (e.g. pneumonia)
• Abdomen
• Genitourinary system
• Primary bloodstream

Pathological Process

Sepsis results when an infectious insult precipitates a localized inflammatory reaction that goes on to cause systemic symptoms of fever or hypothermia, tachycardia, tachypnea, and leukocytosis or leukopenia (a clinical symptoms called systemic inflammatory response syndrome). The inflammatory reaction is mediated by the release of cytokines which activate the extrinsic coagulation cascade and inhibit fibrinolysis. These upshot is microvascular thrombosis, a potential factor producing organ dysfunction. Sepsis is a complex syndrome involving activation of a variety of systems.

Clinical Presentation

Symptoms of sepsis: non-specific and may include:

• Localising symptoms of infection (e.g. productive cough, vomiting, diarrhoea, dysuria)
• Drowsiness
• Confusion
• Dizziness
• Malaise

Clinical signs of sepsis may include:

• Tachycardia
• Hypotension
• Tachypnoea
• Cyanosis
• Fever/hypothermia
• Oliguria
• Non-blanching rash
• Mottled/ashen appearance

Diagnostic Procedures

Septic shock can only be diagnosed when it fits to the clinical criteria and infection (and the pathogen if possible) is verified.

• Identification of infection:
  • Look for obvious signs - e.g. community-aquired pneumonia, prupura fulminans, cellulitis, wound discharge.
  • Blood tests/tissue biopsy or sample to determine pathogen
• Bloods:
  • PCR
  • Microarray based rapid
• Assess for tissue hypoperfusion
  • Glasgow coma scale to determine mental confusion (unable to do in sedated patients)
  • Input and output measures to determine oliguria
• Multi-organ failure

Outcome Measures

• SOFA (sepsis-related organ failure assessment) score
• qSOFA (quick sepsis-related organ failure assessment)

Medical Management

The below guidelines are derived from the Surviving Sepsis Campaign Guidelines

1. Source Control

• Broad-spectrum antibiotics within one hour of diagnosis for all patients. Initial empiric anti-infective therapy should have activity against all likely pathogens and adequate penetration of source tissue.
• Removal of infected/necrotic tissue, if it is the source of septic shock, i.e. patients with cellulitis, abscess, infected devices, purulent wounds.

2. Management of Shock

• Measures most effective if achieved within the first six hours of diagnosis
• Restore central venous pressure (CVP) to 8 mmHg to 12 mmHg
• Restore mean arterial pressure (MAP) greater than 65 mmHg
• Restore superior vena cava saturation to 70% or mixed venous saturation to 65%
• Fluid resuscitation with crystalloid (NS or albumin) and colloid (blood products) up to 80 ml/kg
• Mechanical ventilation to reduce metabolic demand
• First-line vasoactive agents (epinephrine in cold shock versus norepinephrine in warm shock) when fluid-refractory Note: dopamine as a first-line agent has fallen out of favor.

3. Enhancing Host Response

• Corticosteroids indicated in vasoactive-refractory shock and or in patients with low (unstimulated) basal cortisol levels less than 150 ug/L)
• Addition of vasopressin indicated in vasoactive-refractory shock

Also of note

• The placement of an arterial line is important in the management of vasoactive-refractory shock for close monitoring of blood pressure and tissue oxygenation status via regular blood gasses with key attention to lactate levels and pO2.
• Patients with sepsis have a high metabolism and thus prolonged starvation should be avoided. Early nutrition can help protect gut mucosa and prevent translocation of organisms from the GI tract into the systemic circulation.

Physiotherapy management

See the page for the role of physiotherapy in the ICU.

• Physiotherapy interventions in the ICU setting normally consist of respiratory physiotherapy focusing on airway clearance techniques and early mobilization. During acute sepsis or septic shock, patients are often too unstable for physiotherapy intervention, which only starts when the patient is haemodynamically stable.
• Positioning plays a big role in the management of patients with sepsis. A heads-up position of 30-45 degrees is recommended to decrease the risk of aspiration pneumonia and ventilator-associated pneumonia, where prone positioning is recommended in sepsis induced ARDS with a PF ratio of less than 150.
• A common result of these is critical illness neuropathy, and extensive rehabilitation should then be incorporated in the ICU, after discharge to the ward, as well as in the out-patient setting with the aim of getting the patient back to his baseline level of function and participation as per the ICF model.

Prognosis

Septic shock is a serious illness and despite all the advances in medicine, it still carries high mortality which can exceed 40%.

• Mortality does depend on many factors including the type of organism, antibiotic sensitivity, number of organs affected, and patient age.
• The more factors that match SIRS, the higher the mortality.
• Data suggest that tachypnea and altered mental status are excellent predictors of poor outcomes.
• Prolonged use of inotropes to maintain blood pressure is also associated with adverse outcomes.
• Those who survive are left with significant functional and cognitive deficits.

Resources

• Surviving Sepsis Guidelines and Bundles
• Hospital Toolkit for Adult Sepsis Surveillance